Research Metadata
Cross-source consensus on Research Metadata from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Benefits
Other
Highlighted claims
- Research provenance is critical to integrity, quality appraisal, impact evaluation, and trust. — An Open Pharma Vision for company-sponsored biomedical research publications
- The immediate call is to include ORCID iDs for company authors and improve organisation and grant identifier use among authors, contributors, and funders. — An Open Pharma Vision for company-sponsored biomedical research publications
- Metadata provide proof of provenance in digital publishing. — An Open Pharma Vision for company-sponsored biomedical research publications
- Persistent identifiers provide durable references to digital objects. — An Open Pharma Vision for company-sponsored biomedical research publications
- Persistent identifiers make research easier to find, authenticate, and curate because they are machine readable, searchable, and integrable across systems. — An Open Pharma Vision for company-sponsored biomedical research publications
- ORCID iDs reduce ambiguity among authors with similar names and unify publication records for authors who changed names. — An Open Pharma Vision for company-sponsored biomedical research publications